Biochemical and renal-metabolic profiles distinguishing primary aldosteronism from essential hypertension: a systematic review and meta-analysis with implications for endocrine hypertension screening - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Differentiating Primary Aldosteronism from Essential Hypertension: A Systematic Review and Meta-Analysis of Biochemical and Renal-Metabolic Profiles for Endocrine Hypertension Screening
Clinical Scorecard: Differentiating Primary Aldosteronism from Essential Hypertension: A Systematic Review and Meta-Analysis of Biochemical and Renal-Metabolic Profiles for Endocrine Hypertension Screening
At a Glance
Category
Detail
Condition
Primary Aldosteronism
Key Mechanisms
Aldosterone promotes distal sodium reabsorption and potassium secretion.
Target Population
Adults with hypertension
Care Setting
Endocrine hypertension screening
Key Highlights
PA characterized by lower serum potassium and higher sodium compared to controls.
Significant differences in renal-metabolic profiles between PA and essential hypertension.
Unilateral PA shows lower potassium levels than bilateral PA.
Elevated urinary albumin and serum uric acid in PA.
Routine filtration measures should include UACR for renal evaluation.
Guideline-Based Recommendations
Diagnosis
Biochemical confirmation of PA through standardized tests.
Management
Unilateral PA may be treated with adrenalectomy; bilateral PA is typically managed medically.
Monitoring & Follow-up
Monitor electrolyte levels and renal function, including UACR.
Risks
Under-recognition of PA in hypertensive populations.
Patient & Prescribing Data
Individuals with hypertension, particularly those with resistant hypertension.
Aldosterone-to-renin ratio (ARR) screening is crucial for identifying PA.
Clinical Best Practices
Incorporate UACR in routine renal evaluations for patients with hypertension.
Avoid relying solely on hypokalemia for PA screening.
